Direct-To-Consumer Genetic Testing Market by Service, and Geography - Forecast and Analysis 2022-2026

The direct-to-consumer genetic testing market share is expected to increase by USD 1.26 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 13.36%.

This direct-to-consumer (DTC) genetic testing market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers direct-to-consumer genetic testing market segmentations by service (diagnostic screening, prenatal, newborn screening, and pre-implantation diagnosis, relationship testing, and others) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The DTC genetic testing market report also offers information on several market vendors, including 23andMe Holding Co., 24GENETICS S.L., Alpha Biolaboratories Ltd., Ancestry, Centrillion Technology Inc., Color Genomics Inc., Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp., Helix OpCo LLC, IntelliGenetics, Invitae Corp., Konica Minolta Inc, Laboratory Corp. of America Holdings, MyHeritage Ltd., Myriad Genetics Inc., Positive Biosciences Ltd., Quest Diagnostics Inc., Sonora Quest Laboratories, Victorian Clinical Genetics Services, and Xcode Life Sciences Pvt. Ltd among others.

What will the Direct-To-Consumer Genetic Testing Market Size be During the Forecast Period?

Download Report Sample to Unlock the Direct-To-Consumer Genetic Testing Market Size for the Forecast Period and Other Important Statistics

 

Direct-To-Consumer Genetic Testing Market: Key Drivers, Trends, and Challenges

The research studied the historical data considered for years, with 2021 as the base year and 2022 as the estimated year, and produced drivers, trends, and challenges market.

Key Direct-To-Consumer Genetic Testing Market Driver

One of the key factors driving the direct-to-consumer genetic testing market growth is the growing adoption of direct-to-consumer genetic testing for early disease diagnosis. Direct-to-consumer genetic testing services are finding increasing adoption worldwide, owing to the significant demand for early disease diagnosis. Furthermore, direct-to-consumer genetic testing provides information on the risk of developing certain genetic diseases, which can help people approach physicians for further monitoring of the risk of developing such diseases and for their early diagnosis and prevention. However, these tests cannot be used to determine the overall risk of disease development. Furthermore, the adoption of direct-to-consumer genetic testing has increased, especially among people with a family history of certain genetic diseases, which have a greater chance of transmission to their progeny. Moreover, the increasing number of people with Alzheimer’s disease, cancer, and Parkinson’s disease has further fueled the demand for these tests. For instance, according to the data stated by the Centers for Disease Control and Prevention (CDC) in 2020, the number of people with Alzheimer’s disease in the US is expected to increase to 14 million by 2060. Therefore, the rising prevalence of diseases and disorders with genetic transmission capabilities has increased the demand for direct-to-consumer genetic testing for early diagnosis and prevention and will drive market growth during the forecast period.

Key Direct-To-Consumer Genetic Testing Market Trend

Advances in next-generation genetic sequencing are another factor supporting the direct-to-consumer genetic testing market growth in the forecast period. The advent of next-generation genetic testing technologies has provided market vendors with a critical resource on the function, structure, and organization of a complete set of human genomes. These technologies have enabled medical researchers to understand variations in genetic sets that cause genetic disorders. Furthermore, next-generation genetic sequencing (NGS) technology has enabled mass sequencing across the human genome for the detection of variants with intermediate to large sizes, which cause diseases/disorders. In addition, NGS has helped to reduce the cost of sequencing significantly, which has led to a paradigm shift in the global DTC genetic testing market by lowering the cost of services. In addition, the global DTC genetic testing market is witnessing a significant number of discoveries for determining common DNA variants associated with complex diseases, such as cancer, CVDs, and diabetes, which account for a substantial share of healthcare expenditure. The rising number of research activities and discoveries in genetic testing for determining genetic variants has enabled market vendors, such as 23andMe, Myriad Genetics, and Quest Diagnostics, to offer a wide variety of prediction tests for blood sugar regulation, cancer, vision loss, and autoimmune disorders.

Key Direct-To-Consumer Genetic Testing Market Challenge

Doubts over analytical and clinical validity will be a major challenge for the direct-to-consumer genetic testing market growth during the forecast period. The analytical and clinical validity of direct-to-consumer genetic testing has been consistently questioned due to the presence of limited scientific evidence. This negatively impacts the commercialization of pre-disposition tests. Moreover, the disease risk prediction capabilities of these tests provide do not provide the overall context for risk assessment, as it excludes the environmental and lifestyle factors, which play a critical role in increasing the risk of getting a disease. Further, the need for consumers to interpret complex results backed by the lack of reliable scientific evidence makes it hard for them to understand, and therefore, they must rely on third parties such as medical practitioners and genetic counselors for reliable interpretation. This leads to additional costs for consultation and increases the overall costs incurred by the consumer. In addition, the issuance of warnings by the US FDA about the regulated genetic testing market in 2018 concerning unauthorized claims by certain pharmacogenetics test providers has restricted the adoption of direct-to-consumer genetic testing services, thereby hindering market growth.

This DTC genetic testing market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global direct-to-consumer genetic testing market as a part of the global life science tools and services market. Our research report has extensively covered the external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the direct-to-consumer genetic testing market during the forecast period.

Who are the Major Direct-To-Consumer Genetic Testing Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

• 23andMe Holding Co.
• 24GENETICS S.L.
• Alpha Biolaboratories Ltd.
• Ancestry
• Centrillion Technology Inc.
• Color Genomics Inc.
• Dante Labs Inc.
• DNA Diagnostic Center Inc.
• Full Genomes Corp.
• Helix OpCo LLC
• IntelliGenetics
• Invitae Corp.
• Konica Minolta Inc
• Laboratory Corp. of America Holdings
• MyHeritage Ltd.
• Myriad Genetics Inc.
• Positive Biosciences Ltd.
• Quest Diagnostics Inc.
• Sonora Quest Laboratories
• Victorian Clinical Genetics Services
• Xcode Life Sciences Pvt. Ltd

 

This statistical study of the DTC genetic testing market encompasses successful business strategies deployed by the key vendors. The direct-to-consumer genetic testing market is fragmented, and the vendors are deploying growth strategies such as market expansion, investments, and distribution networks to compete in the market.

Product Insights and News

Alpha Biolaboratories Ltd. - The company provides a comprehensive range of direct-to-consumer genetic testing to consumers, such as Paternity Testing, Legal DNA testing, Immigration DNS testing, Aunt testing, Grandparents testing, and others.

To make the most of the opportunities and recover from the post-COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments while maintaining their positions in the slow-growing segments.

The vendor profiles are designed to help clients improve their market position and information on production and sustainability along with this the report provides a detailed analysis of several leading Companies.

Direct-To-Consumer Genetic Testing Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain and parent market of the DTC genetic testing market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies The players across the value chain includes selective data and analysis from entire research findings as per the scope of the report.

The report has further elucidated other innovative approaches being followed by service providers to ensure a sustainable market presence.

Which are the Key Regions for Direct-To-Consumer Genetic Testing Market?

For more insights on the market share of various regions Request PDF Sample now!

38% of the market’s growth will originate from North America during the forecast period. The US is the key market for the direct-to-consumer genetic testing market in North America. Market growth in this region will be faster than the growth of the market in other regions.

The high prevalence of chronic diseases, such as cancer and diabetes will facilitate the direct-to-consumer genetic testing market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID-19 Impact and Recovery Analysis

The outbreak of the COVID-19 pandemic in the region has influenced the demand for various genetic testing kits, which will further drive market growth in North America. The COVID-19 Test Home Collection Test Kit DTC is available without a doctor's prescription and can be given directly to individuals who are not experiencing symptoms of COVID-19. Negative results are delivered directly to the individual via email, while positive results will be delivered through a healthcare provider to the individual.

What are the Revenue-generating Service Segments in the Direct-To-Consumer Genetic Testing Market?

To gain further insights on the market contribution of various segments Request a PDF Sample

The direct-to-consumer genetic testing market share growth in the diagnostic screening segment will be significant during the forecast period. Direct-to-consumer genetic tests are diagnostic tools that provide critical information on the risk of a consumer (of the testing kit) getting an inherited/genetic disease and also indicate their predisposition to such a disease. Therefore, increasing demand for the early diagnosis of diseases has boosted revenue generation in the diagnostic screening segment.

This report provides an accurate prediction of the contribution of all the segments to the growth of the direct-to-consumer genetic testing market size and actionable market insights on the post-COVID-19 impact on each segment.

 

Direct-To-Consumer Genetic Testing Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 13.36%
Market growth 2022-2026	$1.26 billion
Market structure	Fragmented
YoY growth (%)	12.4
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 38%
Key consumer countries	US, Germany, UK, France, and China
Competitive landscape	Leading companies, Competitive Strategies, Consumer engagement scope
Key companies profiled	23andMe Holding Co., 24GENETICS S.L., Alpha Biolaboratories Ltd., Ancestry, Centrillion Technology Inc., Color Genomics Inc., Dante Labs Inc., DNA Diagnostic Center Inc., Full Genomes Corp., Helix OpCo LLC, IntelliGenetics, Invitae Corp., Konica Minolta Inc, Laboratory Corp. of America Holdings, MyHeritage Ltd., Myriad Genetics Inc., Positive Biosciences Ltd., Quest Diagnostics Inc., Sonora Quest Laboratories, Victorian Clinical Genetics Services, and Xcode Life Sciences Pvt. Ltd
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this Direct-To-Consumer Genetic Testing Market Report?

• CAGR of the market during the forecast period 2022-2026
• Detailed information on factors that will drive direct-to-consumer genetic testing market growth during the next five years
• Precise estimation of the direct-to-consumer genetic testing market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the direct-to-consumer genetic testing industry across North America, Europe, Asia, and the Rest of the World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of direct-to-consumer genetic testing market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch